T. Rowe Price Associates’s KRONOS Worldwide KRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Buy
59,976
+5,510
+10% +$37.8K ﹤0.01% 2751
2026
Q1
$358K Hold
54,466
– – ﹤0.01% 2595
2025
Q4
$241K Buy
54,466
+30,100
+124% +$146K ﹤0.01% 2742
2025
Q3
$140K Buy
24,366
+1,762
+8% +$10.7K ﹤0.01% 2867
2025
Q2
$141K Sell
22,604
-200
-0.9% -$1.37K ﹤0.01% 2817
2025
Q1
$171K Buy
22,804
+1,797
+9% +$15.8K ﹤0.01% 2704
2024
Q4
$205K Buy
21,007
+930
+5% +$10.4K ﹤0.01% 2672
2024
Q3
$250K Buy
20,077
+1,009
+5% +$11.7K ﹤0.01% 2553
2024
Q2
$240K Buy
19,068
+601
+3% +$7.59K ﹤0.01% 2521
2024
Q1
$218K Buy
18,467
+216
+1% +$2.09K ﹤0.01% 2579
2023
Q4
$182K Buy
18,251
+763
+4% +$6.2K ﹤0.01% 2573
2023
Q3
$136K Buy
17,488
+613
+4% +$5.33K ﹤0.01% 2598
2023
Q2
$148K Buy
+16,875
New +$149K ﹤0.01% 2609
2016
Q3
– Sell
-13,500
Closed -$71K – 2545
2016
Q2
$71K Hold
13,500
– – ﹤0.01% 2463
2016
Q1
$77K Hold
13,500
– – ﹤0.01% 2441
2015
Q4
$76K Buy
+13,500
New +$90.3K ﹤0.01% 2449

Other funds holding KRO

T. Rowe Price Associates's KRO Position: Q2 2026 in Review

T. Rowe Price Associates increased its KRONOS Worldwide (KRO) stake by 10% in Q2 2026, buying an estimated $37.8K and bringing the position to 59,976 shares worth $380K. The position accounts for ﹤0.01% of the portfolio, ranked #2751.

T. Rowe Price Associates first reported a position in KRO in Q4 2015 and has held it in 16 quarters since. 132 funds tracked by Wall St. Rank hold KRO as of Q2 2026.

  • T. Rowe Price Associates held 59,976 shares of KRONOS Worldwide worth $380K as of Q2 2026.
  • T. Rowe Price Associates bought 5,510 KRONOS Worldwide shares in Q2 2026, an estimated $37.8K.
  • KRONOS Worldwide made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2751 holding.
  • T. Rowe Price Associates first reported a position in KRONOS Worldwide in Q4 2015 and has held it in 16 quarters since.
  • 132 funds tracked by Wall St. Rank held KRONOS Worldwide as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.